{
    "organizations": [],
    "uuid": "1c4f68531000e0510215e081024132480eb91a69",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-kangmei-pharmaceutical-gets-approv/brief-kangmei-pharmaceutical-gets-approval-to-issue-6-5-billion-yuan-commercial-paper-idUSH9N1QO021",
    "ord_in_thread": 0,
    "title": "BRIEF-Kangmei Pharmaceutical Gets Approval To Issue 6.5 Billion Yuan Commercial Paper",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 9 (Reuters) - Kangmei Pharmaceutical Co Ltd :\n* SAYS IT GETS APPROVAL TO ISSUE 6.5 BILLION YUAN ($1.03 billion) COMMERCIAL PAPER Source text in Chinese: bit.ly/2FoZzg6 Further company coverage: ($1 = 6.3303 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)\n ",
    "published": "2018-03-09T19:48:00.000+02:00",
    "crawled": "2018-03-10T20:10:53.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "kangmei",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "get",
        "approval",
        "issue",
        "billion",
        "yuan",
        "billion",
        "commercial",
        "paper",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "chinese",
        "yuan",
        "renminbi",
        "reporting",
        "hong",
        "kong",
        "newsroom"
    ]
}